Darren Huston On Wattpad, Chief Executive Officer,

Darren Huston On Wattpad, Chief Executive Officer,

Darren Huston On Wattpad, Chief Executive Officer,

Born: January 3, 1966, Hope, British Columbia.

Education: BS in economics, Trent University; MA in Economics, University of British Columbia; MBA, Harvard Business School.

Early Marker: Vice president at Starbucks responsible for acquisitions and new product development.

Big Idea: The Microsoft executive stepped up to the top job at Priceline in January 2014 after running the group’s main revenue generator, Amsterdam-based Booking.com. Since 2011 he has been tackling the challenges of its main advertising outlet, Google, increasingly competing with it for travel-related bookings, of expanding its hospitality-related services, such as with its acquisition of OpenTable, and of retaining its customers as they migrate from desktop to mobile devices.

More Posts from Sumitsood21 and Others

5 years ago

How I Raised It with Sachin Dev Duggal of Engineer.ai

Produced by Foundersuite.com, “How I Raised It” goes behind the scenes with startup founders who have raised capital.

This episode is with Sachin Dev Duggal, CEO of Engineer.ai a Santa Monica based startup that provides a human-assisted AI platform to build custom software products.

Engineer.ai raised a $29.5 million Series A venture rounds in a deal led by Lakestar Advisors (Germany) Jungle Ventures (Singapore) and Deepcore (Japan).

In this episode, Sachin Dev Duggal talks about raising capital for a startup whose “front end is SaaS and back end is a marketplace,” some of the fundraising false starts, why he believes the funding success formula is made up of “purpose + persistence” and more.

Read full story @ https://open.spotify.com/episode/0QbAUveHF8oA0vsSjnkvpk

5 years ago
Darren Huston
President and CEO, Darren Huston

President and CEO, Darren Huston


Tags
5 years ago

Darren Huston, Priceline Group Pres. & CEO, discusses business and investment strategies and Priceline for the Apple Watch.


Tags
5 years ago

Priceline Group president and CEO Darren Huston, discusses the global business of Priceline and the company's plans for international growth.


Tags
5 years ago

CEO Darren Huston steps up - CNBC.com


Tags
5 years ago

After beating earnings expectations, the Priceline Group CEO Darren Huston, discusses how macro factors like oil and terrorism impact the travel environment.


Tags
5 years ago

Nivio Offers Windows + Office and Your Favorite Apps on Any Connected Device. Sachin Dev Duggal is Nivio Co-Founder & Chief Wizard. Currently he is CEO of Engineer.ai

5 years ago

Sachin Dev Duggal has bootstrapped Engineer.ai since 2012, which was created with the belief that everyone should be able to build their ideas without needing to code and that any idea can be made into a reality without wastage of time, money or resources.

5 years ago

How AI Will Change Medicine

The biomedical world is flooded with information. We have terabytes of genomic data from mouse to human, troves of wellbeing measurements from clinical preliminaries, and reams of purported genuine information from insurance agencies and drug stores. Utilizing ground-breaking PCs, researchers have investigated this abundance with some fine outcomes, yet it has become certain that we can adapt significantly more with a help from artificial intelligence. Throughout the following decade profound learning neural systems will probably change what we look like for designs in information and how research is directed and applied to human wellbeing. This uncommon report investigates the guarantee of this incipient unrest.

At this moment the greatest wagers are being set in the domain of medication disclosure. What’s more, all things considered. The normal expense of putting up another medication for sale to the public almost multiplied somewhere in the range of 2003 and 2013 to $2.6 billion, and in light of the fact that nine out of 10 flop in the last two periods of clinical preliminaries, the greater part of the cash goes to squander. Each enormous pharma organization is working with in any event one Engineer AI - centered beginning up to check whether it can raise the arrival on venture. AI calculations can filter through a large number of mixes, narrowing the choices for a specific medication target. Maybe all the more energizing, AI frameworks—unconstrained by winning hypotheses and predispositions—can distinguish altogether new focuses by spotting inconspicuous contrasts at the degree of tissues, cells, qualities or proteins between, state, a sound mind and one set apart by Parkinson's—contrasts that may evade or even confuse a human researcher.

That equivalent sharp-looked at capacity is additionally being sent to decipher restorative sweeps. A few frameworks would already be able to identify early indications of malignancy that may be missed by a radiologist or see things that are basically past human limit, for example, evaluating cardiovascular hazard from a retinal sweep. The Food and Drug Administration is supporting imaging calculations at a fast clasp. Other AI applications lie somewhat further not far off. Will the wasteful aspects of the present electronic wellbeing records (EHRs) be tended to by shrewd frameworks that avoid endorsing mistakes and give early admonitions of illness? A portion of the world’s greatest tech goliaths are chipping away at it.

Notwithstanding fears that machines will dislodge people, most specialists accept fake and human insight will work synergistically. The greater concern is a deficiency of individuals with both biomedical information and calculation building capability. In the event that this human issue can be settled, the way to making fruitful AI applications may rely upon the quality and amount of what we feed their ravenous throat. “We depend on three things,” says the CEO of one profound learning fire up. “Information, information and more information.”

This report, distributed in Scientific American and Nature, is supported by F. Hoffmann-La Roche Ltd. It was delivered autonomously by the editors of Scientific American, who assume sole liability for the publication content.

Read full story @ https://www.nature.com/articles/d41586-019-03845-1


Tags
Loading...
End of content
No more pages to load
sumitsood21 - Sujan Azad Parikh Posts
Sujan Azad Parikh Posts

Posts of Sujan Azad Parikh on Casemine.

40 posts

Explore Tumblr Blog
Search Through Tumblr Tags